A landmark 10-year follow-up study has delivered a stark verdict on one of the world’s most common orthopedic procedures: partial meniscectomy offers no benefit over sham surgery and may actually accelerate joint damage.
The findings, published in the New England Journal of Medicine, suggest that this routine operation—designed to trim degenerated tissue in the knee—is not only ineffective but potentially harmful. Patients who underwent the surgery reported worse symptoms, poorer function, and a higher likelihood of requiring future knee replacements compared to those who underwent a placebo procedure.
The FIDELITY Trial: A Decade of Evidence
The data comes from the Finnish Degenerative Meniscal Lesion Study (FIDELITY), a rigorous randomized controlled trial that included a sham surgery control group. This design is critical because it isolates the physiological effects of the surgery from the psychological benefits of undergoing a medical procedure.
Over a decade, the study tracked 146 patients with degenerative meniscal tears. The results were unequivocal:
* No Improvement: There was no significant difference in pain or functional outcomes between the surgery group and the sham group.
* Worse Outcomes: Patients who received the actual surgery experienced greater progression of osteoarthritis.
* Higher Risk: The surgical group had a significantly higher rate of subsequent knee replacements.
“Our findings suggest that this may be an example of what is known as a medical reversal, where broadly used therapy proves ineffective or even harmful,” says Teppo Järvinen, Professor at the University of Helsinki and principal investigator of the study.
Challenging Biological Assumptions
The persistence of partial meniscectomy highlights a common pitfall in medicine: treating symptoms based on anatomical findings rather than clinical evidence.
The traditional logic assumes that a tear in the medial meniscus (the cushioning cartilage in the knee) is the direct cause of pain, and that removing the torn fragment will relieve that pain. However, lead researcher Raine Sihvonen argues that this reasoning does not withstand critical examination.
“Based on current understanding, pain in various joints, such as the knee joint in this case, is related to degeneration brought about by aging,” explains Sihvonen. In other words, the meniscal tear is often a marker of wear and tear, not the primary source of pain. Trimming the tear does not address the underlying degenerative process.
The Gap Between Evidence and Practice
Despite mounting evidence, partial meniscectomy remains widely performed globally. This discrepancy raises important questions about how medical guidelines are adopted and enforced.
- Observational Data: Earlier registry studies had already linked the procedure to higher risks of joint replacement, but such data cannot prove causation.
- Short-Term Trials: Previous randomized studies showed no benefit at 1–2 years or 5 years, yet the procedure continued.
- Guideline Lag: While many independent, non-orthopedic organizations have recommended discontinuing the surgery for nearly a decade, major bodies like the American Academy of Orthopaedic Surgeons (AAOS) and the British Association for Surgery of the Knee (BASK) have continued to endorse it.
Dr. Roope Kalske, a specialist in orthopaedics and traumatology involved in the study, notes that this illustrates the difficulty of abandoning inefficient therapies once they become entrenched in clinical practice.
Why This Matters
The FIDELITY trial serves as a powerful case study in evidence-based medicine. It demonstrates that:
1. Sham controls are essential for evaluating surgical efficacy, particularly for procedures with strong placebo effects.
2. Anatomical abnormalities seen on MRI scans do not always correlate with pain sources.
3. Long-term follow-up is necessary to detect delayed harms, such as accelerated osteoarthritis.
As Järvinen concludes, “This effectively illustrates how difficult it is to give up inefficient therapies.” The study’s high retention rate—with over 90% of participants remaining in the final stage—underscores the robustness of the data and the importance of patient commitment to long-term research.
Conclusion
The 10-year FIDELITY trial provides compelling evidence that partial meniscectomy for degenerative meniscal tears is clinically ineffective and potentially detrimental. These findings challenge the medical community to reevaluate standard practices, prioritize long-term outcomes over short-term anatomical fixes, and align surgical recommendations with robust, longitudinal data.
